26th April 2023 Orbital Therapeutics Secures $270 Million in Series A Financing to Unleash Full Potential of RNA Medicines
7th September 2022 Orbital Therapeutics Launches to Advance New Frontiers of Science with the Next Generation of Innovative RNA Medicines